Overview
Borys Hrinczenko is a Hematologist practicing medicine in Lansing, Michigan.
Dr. Hrinczenko is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Sickle Cell Disease, Thrombocytopenia, and ALK-Positive Non-Small Cell Lung Cancer.
He is actively involved in clinical research, co-authoring 29 peer reviewed articles and participating in 5 clinical trials. Dr. Hrinczenko is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
401 W Greenlawn Ave, Lansing, MI 48910
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.
C. S. Mott Children's Hospital
Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology. Dr. Bixby is currently accepting new patients.
Edward W. Sparrow Hospital Association
Gordon Srkalovic is a Hematologist practicing medicine in Lansing, Michigan. Dr. Srkalovic is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Castleman Disease, Unicentric Castleman Disease (UCD), Multicentric Castleman Disease (MCD), and ALK-Positive Non-Small Cell Lung Cancer. Dr. Srkalovic is currently accepting new patients.
Frequently Asked Questions about Dr. Borys W. Hrinczenko
How do I make an appointment with Dr. Borys W. Hrinczenko?
You can book an appointment with Dr. Borys W. Hrinczenko by calling their office at 517-975-9500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Borys W. Hrinczenko a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Borys W. Hrinczenko is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Borys W. Hrinczenko specialize in?
While Dr. Borys W. Hrinczenko is a Hematology, they have specific expertise in Multiple Myeloma, Sickle Cell Disease, and Thrombocytopenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Borys W. Hrinczenko participate in research or clinical trials?
Yes. Dr. Borys W. Hrinczenko has published 29 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Borys W. Hrinczenko's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Borys W. Hrinczenko accept my insurance?
Dr. Borys W. Hrinczenko accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 517-975-9500 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Hrinczenko isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Hrinczenko isAdvanced. Learn about Anemia.
- Multiple MyelomaDr. Hrinczenko isAdvanced. Learn about Multiple Myeloma.
- Sickle Cell DiseaseDr. Hrinczenko isAdvanced. Learn about Sickle Cell Disease.
- ThrombocytopeniaDr. Hrinczenko isAdvanced. Learn about Thrombocytopenia.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Hrinczenko isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Lymphoblastic Leukemia (ALL)Dr. Hrinczenko isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Immune ThrombocytopeniaDr. Hrinczenko isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Hrinczenko isExperienced. Learn about Agranulocytosis.
- Autoimmune Hemolytic AnemiaDr. Hrinczenko isExperienced. Learn about Autoimmune Hemolytic Anemia.
- B-Cell LymphomaDr. Hrinczenko isExperienced. Learn about B-Cell Lymphoma.
- Childhood Acute Myeloid LeukemiaDr. Hrinczenko isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Hrinczenko isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Hrinczenko isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Dr. Hrinczenko isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Congenital Hemolytic AnemiaDr. Hrinczenko isExperienced. Learn about Congenital Hemolytic Anemia.
- Deep Vein ThrombosisDr. Hrinczenko isExperienced. Learn about Deep Vein Thrombosis.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Hrinczenko isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Essential ThrombocythemiaDr. Hrinczenko isExperienced. Learn about Essential Thrombocythemia.
- Febrile NeutropeniaDr. Hrinczenko isExperienced. Learn about Febrile Neutropenia.
- Follicular LymphomaDr. Hrinczenko isExperienced. Learn about Follicular Lymphoma.
- Gastric LymphomaDr. Hrinczenko isExperienced. Learn about Gastric Lymphoma.
- Gastroesophageal Junction CancerDr. Hrinczenko isExperienced. Learn about Gastroesophageal Junction Cancer.
- Hairy Cell Leukemia (HCL)Dr. Hrinczenko isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Hemangioma Thrombocytopenia SyndromeDr. Hrinczenko isExperienced. Learn about Hemangioma Thrombocytopenia Syndrome.
- Hemoglobin SC DiseaseDr. Hrinczenko isExperienced. Learn about Hemoglobin SC Disease.
- Hemolytic AnemiaDr. Hrinczenko isExperienced. Learn about Hemolytic Anemia.
- Hemophilia ADr. Hrinczenko isExperienced. Learn about Hemophilia A.
- Hemophilic ArthropathyDr. Hrinczenko isExperienced. Learn about Hemophilic Arthropathy.
- Hypereosinophilic SyndromeDr. Hrinczenko isExperienced. Learn about Hypereosinophilic Syndrome.
- Idiopathic NeutropeniaDr. Hrinczenko isExperienced. Learn about Idiopathic Neutropenia.
- Immune Thrombocytopenic Purpura (ITP)Dr. Hrinczenko isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- Large-Cell Immunoblastic LymphomaDr. Hrinczenko isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- LeukemiaDr. Hrinczenko isExperienced. Learn about Leukemia.
- LeukocytosisDr. Hrinczenko isExperienced. Learn about Leukocytosis.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Myelodysplastic Syndrome (MDS)Dr. Hrinczenko isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- MyelofibrosisDr. Hrinczenko isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Dr. Hrinczenko isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Non-Hodgkin LymphomaDr. Hrinczenko isExperienced. Learn about Non-Hodgkin Lymphoma.
- Philadelphia-Negative Chronic Myeloid LeukemiaDr. Hrinczenko isExperienced. Learn about Philadelphia-Negative Chronic Myeloid Leukemia.
- Polycythemia VeraDr. Hrinczenko isExperienced. Learn about Polycythemia Vera.
- PorphyriaDr. Hrinczenko isExperienced. Learn about Porphyria.
- Primary Immunodeficiency (PID)Dr. Hrinczenko isExperienced. Learn about Primary Immunodeficiency (PID).
- Pulmonary EmbolismDr. Hrinczenko isExperienced. Learn about Pulmonary Embolism.
- ReticuloendotheliosisDr. Hrinczenko isExperienced. Learn about Reticuloendotheliosis.
- Richter SyndromeDr. Hrinczenko isExperienced. Learn about Richter Syndrome.
- Schnitzler SyndromeDr. Hrinczenko isExperienced. Learn about Schnitzler Syndrome.
- Shwartzman PhenomenonDr. Hrinczenko isExperienced. Learn about Shwartzman Phenomenon.
- Smoldering Multiple MyelomaDr. Hrinczenko isExperienced. Learn about Smoldering Multiple Myeloma.
- SplenomegalyDr. Hrinczenko isExperienced. Learn about Splenomegaly.
- ThalassemiaDr. Hrinczenko isExperienced. Learn about Thalassemia.
- Venous Thromboembolism (VTE)Dr. Hrinczenko isExperienced. Learn about Venous Thromboembolism (VTE).
- Vitamin B12 DeficiencyDr. Hrinczenko isExperienced. Learn about Vitamin B12 Deficiency.
- Waldenstrom MacroglobulinemiaDr. Hrinczenko isExperienced. Learn about Waldenstrom Macroglobulinemia.

